Cargando…
Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology
Human prion diseases are fatal neurodegenerative disorders with a genetic, sporadic or infectiously acquired aetiology. Neuropathologically, human prion diseases are characterized by deposition of misfolded prion protein and neuronal loss. In post-mortem brain tissue from patients with other neurode...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086055/ https://www.ncbi.nlm.nih.gov/pubmed/27793194 http://dx.doi.org/10.1186/s40478-016-0383-7 |
_version_ | 1782463674137444352 |
---|---|
author | Wiersma, Vera I. van Hecke, Wim Scheper, Wiep van Osch, Martijn A. J. Hermsen, Will J. M. Rozemuller, Annemieke J. M. Hoozemans, Jeroen J. M. |
author_facet | Wiersma, Vera I. van Hecke, Wim Scheper, Wiep van Osch, Martijn A. J. Hermsen, Will J. M. Rozemuller, Annemieke J. M. Hoozemans, Jeroen J. M. |
author_sort | Wiersma, Vera I. |
collection | PubMed |
description | Human prion diseases are fatal neurodegenerative disorders with a genetic, sporadic or infectiously acquired aetiology. Neuropathologically, human prion diseases are characterized by deposition of misfolded prion protein and neuronal loss. In post-mortem brain tissue from patients with other neurodegenerative diseases characterized by protein misfolding, including Alzheimer’s disease (AD) and frontotemporal lobar degeneration with tau pathology (FTLD-tau), increased activation of the unfolded protein response (UPR) has been observed. The UPR is a cellular stress response that copes with the presence of misfolded proteins. Recent studies have indicated that UPR activation is also involved in experimental models of prion disease and have suggested intervention in the UPR as a therapeutic strategy. On the other hand, it was previously shown that the active form of the UPR stress sensor dsRNA-activated protein kinase-like ER kinase (PERK) is not increased in post-mortem brain tissue samples from human prion disease cases. In the present study, we assessed the active form of another UPR stress sensor, inositol-requiring enzyme 1α (IRE1α), in human post-mortem frontal cortex of a large cohort of sporadic, inherited and acquired prion disease patients (n = 47) and non-neurological controls. Immunoreactivity for phosphorylated IRE1α was not increased in prion disease cases compared with non-neurological controls. In addition, immunoreactivity for phosphorylated PERK was unaltered in human prion disease cases included in the current cohort. Moreover, no difference in the extent of granulovacuolar degeneration, a pathological feature associated with the presence of UPR activation markers, was detected. Our data indicate that, in contrast to AD and primary tauopathies, activation of the UPR is not a common feature of human prion pathology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-016-0383-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5086055 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50860552016-10-31 Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology Wiersma, Vera I. van Hecke, Wim Scheper, Wiep van Osch, Martijn A. J. Hermsen, Will J. M. Rozemuller, Annemieke J. M. Hoozemans, Jeroen J. M. Acta Neuropathol Commun Research Human prion diseases are fatal neurodegenerative disorders with a genetic, sporadic or infectiously acquired aetiology. Neuropathologically, human prion diseases are characterized by deposition of misfolded prion protein and neuronal loss. In post-mortem brain tissue from patients with other neurodegenerative diseases characterized by protein misfolding, including Alzheimer’s disease (AD) and frontotemporal lobar degeneration with tau pathology (FTLD-tau), increased activation of the unfolded protein response (UPR) has been observed. The UPR is a cellular stress response that copes with the presence of misfolded proteins. Recent studies have indicated that UPR activation is also involved in experimental models of prion disease and have suggested intervention in the UPR as a therapeutic strategy. On the other hand, it was previously shown that the active form of the UPR stress sensor dsRNA-activated protein kinase-like ER kinase (PERK) is not increased in post-mortem brain tissue samples from human prion disease cases. In the present study, we assessed the active form of another UPR stress sensor, inositol-requiring enzyme 1α (IRE1α), in human post-mortem frontal cortex of a large cohort of sporadic, inherited and acquired prion disease patients (n = 47) and non-neurological controls. Immunoreactivity for phosphorylated IRE1α was not increased in prion disease cases compared with non-neurological controls. In addition, immunoreactivity for phosphorylated PERK was unaltered in human prion disease cases included in the current cohort. Moreover, no difference in the extent of granulovacuolar degeneration, a pathological feature associated with the presence of UPR activation markers, was detected. Our data indicate that, in contrast to AD and primary tauopathies, activation of the UPR is not a common feature of human prion pathology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-016-0383-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-10-28 /pmc/articles/PMC5086055/ /pubmed/27793194 http://dx.doi.org/10.1186/s40478-016-0383-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Wiersma, Vera I. van Hecke, Wim Scheper, Wiep van Osch, Martijn A. J. Hermsen, Will J. M. Rozemuller, Annemieke J. M. Hoozemans, Jeroen J. M. Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology |
title | Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology |
title_full | Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology |
title_fullStr | Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology |
title_full_unstemmed | Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology |
title_short | Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology |
title_sort | activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086055/ https://www.ncbi.nlm.nih.gov/pubmed/27793194 http://dx.doi.org/10.1186/s40478-016-0383-7 |
work_keys_str_mv | AT wiersmaverai activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology AT vanheckewim activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology AT scheperwiep activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology AT vanoschmartijnaj activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology AT hermsenwilljm activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology AT rozemullerannemiekejm activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology AT hoozemansjeroenjm activationoftheunfoldedproteinresponseandgranulovacuolardegenerationarenotcommonfeaturesofhumanprionpathology |